WST - WEST PHARMACEUTICAL SERVICES INC
Close
309.35
0 0%
Share volume: 60,254
Last Updated: Tue 24 Dec 2024 04:28:41 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.51%
PREVIOUS CLOSE
CHG
CHG%
$309.35
22.92
0.07%
Fundamental analysis
61%
Profitability
69%
Dept financing
19%
Liquidity
75%
Performance
60%
Performance
5 Days
1.87%
1 Month
3.63%
3 Months
8.04%
6 Months
0.12%
1 Year
-6.63%
2 Year
40.94%
Key data
Stock price
$309.35
DAY RANGE
$329.52 - $332.27
52 WEEK RANGE
$287.05 - $413.70
52 WEEK CHANGE
-$6.63
DIVIDEND
$0.20
EX-DIVIDEND DATE
07/31/2024
NEXT EARNINGS DATE
10/24/2024
Company detail
CEO: Eric M. Green
Region: US
Website: westpharma.com
Employees: 10,700
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: westpharma.com
Employees: 10,700
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The company distributes its products through its sales force and distribution network.
Recent news